Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 29 studies | 37% ± 18% | |
endothelial cell of lymphatic vessel | 20 studies | 41% ± 21% | |
pericyte | 18 studies | 37% ± 17% | |
astrocyte | 15 studies | 33% ± 15% | |
myofibroblast cell | 11 studies | 38% ± 14% | |
endothelial cell | 11 studies | 33% ± 13% | |
smooth muscle cell | 10 studies | 36% ± 15% | |
connective tissue cell | 8 studies | 49% ± 17% | |
glutamatergic neuron | 8 studies | 35% ± 18% | |
GABAergic neuron | 7 studies | 36% ± 12% | |
interneuron | 5 studies | 29% ± 10% | |
oligodendrocyte precursor cell | 4 studies | 22% ± 5% | |
progenitor cell | 3 studies | 41% ± 19% | |
abnormal cell | 3 studies | 30% ± 7% | |
neuron | 3 studies | 30% ± 14% | |
endothelial cell of sinusoid | 3 studies | 44% ± 34% | |
ependymal cell | 3 studies | 47% ± 11% | |
adventitial cell | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 4603.04 | 2612 / 2642 | 100% | 97.98 | 703 / 705 |
prostate | 100% | 7012.35 | 245 / 245 | 96% | 30.36 | 481 / 502 |
lung | 100% | 6302.32 | 577 / 578 | 79% | 16.47 | 914 / 1155 |
thymus | 98% | 2593.60 | 643 / 653 | 65% | 12.49 | 393 / 605 |
ovary | 100% | 8402.85 | 180 / 180 | 62% | 12.20 | 268 / 430 |
kidney | 100% | 4464.88 | 89 / 89 | 60% | 17.34 | 543 / 901 |
adrenal gland | 100% | 5733.47 | 258 / 258 | 59% | 9.57 | 136 / 230 |
stomach | 87% | 3553.34 | 314 / 359 | 69% | 14.06 | 197 / 286 |
breast | 93% | 3081.60 | 425 / 459 | 62% | 16.98 | 692 / 1118 |
bladder | 100% | 6627.81 | 21 / 21 | 54% | 8.97 | 271 / 504 |
uterus | 100% | 6242.94 | 170 / 170 | 52% | 15.61 | 238 / 459 |
esophagus | 90% | 1938.85 | 1307 / 1445 | 56% | 7.52 | 102 / 183 |
intestine | 71% | 1129.71 | 686 / 966 | 69% | 11.58 | 363 / 527 |
liver | 71% | 934.01 | 161 / 226 | 60% | 11.16 | 244 / 406 |
pancreas | 30% | 336.09 | 100 / 328 | 85% | 17.61 | 152 / 178 |
skin | 30% | 938.21 | 551 / 1809 | 44% | 8.46 | 210 / 472 |
adipose | 66% | 2883.95 | 790 / 1204 | 0% | 0 | 0 / 0 |
spleen | 65% | 954.59 | 157 / 241 | 0% | 0 | 0 / 0 |
heart | 43% | 805.19 | 367 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 38% | 4.65 | 17 / 45 |
eye | 0% | 0 | 0 / 0 | 11% | 1.17 | 9 / 80 |
lymph node | 0% | 0 | 0 / 0 | 10% | 1.45 | 3 / 29 |
blood vessel | 8% | 95.63 | 111 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 1.00 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0030522 | Biological process | intracellular receptor signaling pathway |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0010977 | Biological process | negative regulation of neuron projection development |
GO_0030154 | Biological process | cell differentiation |
GO_0048856 | Biological process | anatomical structure development |
GO_0007399 | Biological process | nervous system development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0044323 | Molecular function | retinoic acid-responsive element binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NR2F1 |
Protein name | Ovalbumin upstream promoter-transcription factor I Nuclear receptor subfamily 2 group F member 1 (Ovalbumin upstream promoter-transcription factor I) Nuclear receptor subfamily 2 group F member 1 COUP transcription factor 1 (COUP-TF1) (COUP transcription factor I) (COUP-TF I) (Nuclear receptor subfamily 2 group F member 1) (V-erbA-related protein 3) (EAR-3) |
Synonyms | TFCOUP1 EAR3 ERBAL3 |
Description | FUNCTION: Coup (chicken ovalbumin upstream promoter) transcription factor binds to the ovalbumin promoter and, in conjunction with another protein (S300-II) stimulates initiation of transcription. Binds to both direct repeats and palindromes of the 5'-AGGTCA-3' motif. Represses transcriptional activity of LHCG. . |
Accessions | F1DAL8 A0A8V8TPV3 F1DAL9 ENST00000327111.8 F1DAL6 F1DAL7 A0A8V8TQQ6 ENST00000512697.2 P10589 ENST00000615873.2 ENST00000502982.2 ENST00000647447.1 ENST00000700211.1 |